{{d1.updDate | date:'dd/MM/yyyy'}}
{{d1.vl | number: 3 }} TND
{{d1.perf | number: 3 }}%
{{d1.updDate | date:'dd/MM/yyyy'}}
{{d2.vl | number: 3 }} TND
{{d2.perf | number: 3 }}%
{{d1.updDate | date:'dd/MM/yyyy'}}
{{d3.vl | number: 3 }} TND
{{d3.perf | number:3 }}%
{{d1.updDate | date:'dd/MM/yyyy'}}
{{d4.vl | number: 3 }} TND
{{d4.perf | number: 3 }}%
{{d1.updDate | date:'dd/MM/yyyy'}}
{{d5.vl | number: 3 }} TND
{{d5.perf | number: 3 }}%
KILANI HOLDING PHARMACEUTICALS a acquis en bourse du 28 juillet 2022 2 182 590 titres Adwya ramenant sa participation dans le capital de la société à 50,131%.
